Showing 3421-3430 of 10618 results for "".
Lysergic Acid Diethylamide...Say That 10 Times Fast
https://reachmd.com/programs/rub-some-dirt-in-it/lysergic-acid-diethylamidesay-10-times-fast/10197/Take a trip with us as we look at the scientist who was the first person to synthesize, ingest, and learn of the psychedelic effects of LSD.Pancreatic Cancer: The Hunt to Catch a Silent Killer
https://reachmd.com/programs/project-oncology/pancreatic-cancer-the-hunt-to-catch-silent-killer/9697/Dr. Harish Lavu discusses diagnostic and therapeutic priorities for pancreatic cancer, one of the most deadly oncologic diseases.The OB/GYN Hospitalist Model: Delivering Increased Patient Safety and Satisfaction
https://reachmd.com/programs/clinicians-roundtable/the-obgyn-hospitalist-model-delivering-increased-patient-safety-and-satisfaction/8434/Dr. Rob Olson provides an overview of OB/GYN hospitalists, and how models of care incorporating these clinicians can benefit at different levels.Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
https://reachmd.com/programs/neurofrontiers/program-name/36462/Managing Margins Without Sacrificing Care
https://reachmd.com/programs/modern-optometry/managing-margins-without-sacrificing-care/39993/Hepatocellular Carcinoma: Evaluating the Evolving Treatment Landscape
https://reachmd.com/programs/project-oncology/hepatocellular-carcinoma-evaluating-the-evolving-treatment-landscape/13526/Learn more about the latest updates—and what's on the horizon—for the treatment of hepatocellular carcinoma.Hepatic Encephalopathy: An Ominous Sign
https://reachmd.com/cme/gastroenterology-and-hepatology/hepatic-encephalopathy-an-ominous-sign/39278/Learn how PCPs can identify early signs of hepatic encephalopathy to support timely diagnosis and clinical management.Neoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
https://reachmd.com/programs/project-oncology/neoadjuvant-nivolumab-with-or-without-ipilimumab-in-resectable-cscc/54700/Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
https://reachmd.com/programs/project-oncology/mbc-biopsies-map-immune-response-her2-tri-blockade/49186/Hair Restoration for Generation X
https://reachmd.com/topics/injectables/hair-restoration-for-generation-x/48725/A Conversation With Suneel Chilukuri, MD, FAAD, FACMS